{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:22:38Z","timestamp":1792801358014,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["K2012-57X-22047-01-6"],"award-info":[{"award-number":["K2012-57X-22047-01-6"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"name":"V\u00e4stra G\u00f6talandsregionen (SE)","award":["ALFGBG-143331"],"award-info":[{"award-number":["ALFGBG-143331"]}],"id":[{"id":"https:\/\/ror.org\/00a4x6777","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Torsten S\u00f6derbergs Stiftelse (SE)","award":["M112\/11"],"award-info":[{"award-number":["M112\/11"]}],"id":[{"id":"https:\/\/ror.org\/03p9y1j46","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003849","name":"IngaBritt och Arne Lundbergs Forskningsstiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003849","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13075-017-1224-1","type":"journal-article","created":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T20:17:00Z","timestamp":1485980220000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["Blood chemokine profile in untreated early rheumatoid arthritis: CXCL10 as a disease activity marker"],"prefix":"10.1186","volume":"19","author":[{"given":"Jayesh M.","family":"Pandya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Carin","family":"Lundell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inger","family":"Nordstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Theander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Rudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,2]]},"reference":[{"issue":"6937","key":"1224_CR1","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature01661","volume":"423","author":"GS Firestein","year":"2003","unstructured":"Firestein GS. Evolving concepts of rheumatoid arthritis. Nature. 2003;423(6937):356\u201361.","journal-title":"Nature"},{"issue":"23","key":"1224_CR2","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","volume":"365","author":"IB McInnes","year":"2011","unstructured":"McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365(23):2205\u201319.","journal-title":"N Engl J Med"},{"key":"1224_CR3","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3389\/fimmu.2015.00384","volume":"6","author":"M Mellado","year":"2015","unstructured":"Mellado M, Martinez-Munoz L, Cascio G, Lucas P, Pablos JL, Rodriguez-Frade JM. T cell migration in rheumatoid arthritis. Front Immunol. 2015;6:384.","journal-title":"Front Immunol."},{"issue":"1","key":"1224_CR4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrrheum.2015.157","volume":"12","author":"Z Szekanecz","year":"2016","unstructured":"Szekanecz Z, Koch AE. Successes and failures of chemokine-pathway targeting in rheumatoid arthritis. Nat Rev Rheumatol. 2016;12(1):5\u201313.","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"1224_CR5","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1136\/annrheumdis-2014-206993","volume":"74","author":"K Raza","year":"2015","unstructured":"Raza K, Filer A. The therapeutic window of opportunity in rheumatoid arthritis: does it ever close? Ann Rheum Dis. 2015;74(5):793\u20134.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"1224_CR6","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/1759720X16654476","volume":"8","author":"F Espinoza","year":"2016","unstructured":"Espinoza F, Fabre S, Pers YM. Remission-induction therapies for early rheumatoid arthritis: evidence to date and clinical implications. Ther Adv Musculoskelet Dis. 2016;8(4):107\u201318.","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"4","key":"1224_CR7","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nrrheum.2012.23","volume":"8","author":"JS Smolen","year":"2012","unstructured":"Smolen JS, Aletaha D, Redlich K. The pathogenesis of rheumatoid arthritis: new insights from old clinical data? Nat Rev Rheumatol. 2012;8(4):235\u201343.","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"1224_CR8","doi-asserted-by":"crossref","first-page":"R784","DOI":"10.1186\/ar1733","volume":"7","author":"K Raza","year":"2005","unstructured":"Raza K, Falciani F, Curnow SJ, Ross EJ, Lee CY, Akbar AN, Lord JM, Gordon C, Buckley CD, Salmon M. Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin. Arthritis Res Ther. 2005;7(4):R784\u201395.","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"1224_CR9","doi-asserted-by":"crossref","first-page":"R196","DOI":"10.1186\/ar3168","volume":"12","author":"R Cascao","year":"2010","unstructured":"Cascao R, Moura RA, Perpetuo I, Canhao H, Vieira-Sousa E, Mourao AF, Rodrigues AM, Polido-Pereira J, Queiroz MV, Rosario HS, et al. Identification of a cytokine network sustaining neutrophil and Th17 activation in untreated early rheumatoid arthritis. Arthritis Res Ther. 2010;12(5):R196.","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"1224_CR10","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1046\/j.1365-2249.2002.01913.x","volume":"129","author":"R Gerli","year":"2002","unstructured":"Gerli R, Bistoni O, Russano A, Fiorucci S, Borgato L, Cesarotti ME, Lunardi C. In vivo activated T cells in rheumatoid synovitis. Analysis of Th1- and Th2-type cytokine production at clonal level in different stages of disease. Clin Exp Immunol. 2002;129(3):549\u201355.","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"1224_CR11","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1189\/jlb.5A0116-025R","volume":"100","author":"JM Pandya","year":"2016","unstructured":"Pandya JM, Lundell AC, Hallstrom M, Andersson K, Nordstrom I, Rudin A. Circulating T helper and T regulatory subsets in untreated early rheumatoid arthritis and healthy control subjects. J Leukoc Biol. 2016;100(4):823\u201333.","journal-title":"J Leukoc Biol"},{"issue":"18","key":"1224_CR12","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1111\/j.1742-4658.2008.06580.x","volume":"275","author":"T Iwamoto","year":"2008","unstructured":"Iwamoto T, Okamoto H, Toyama Y, Momohara S. Molecular aspects of rheumatoid arthritis: chemokines in the joints of patients. FEBS J. 2008;275(18):4448\u201355.","journal-title":"FEBS J"},{"issue":"6","key":"1224_CR13","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1136\/ard.2006.054924","volume":"66","author":"W Hueber","year":"2007","unstructured":"Hueber W, Tomooka BH, Zhao XY, Kidd BA, Drijfhout JW, Fries JF, van Venrooij WJ, Metzger AL, Genovese MC, Robinson WH. Proteomic analysis of secreted proteins in early rheumatoid arthritis: anti-citrulline autoreactivity is associated with up regulation of proinflammatory cytokines. Ann Rheum Dis. 2007;66(6):712\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"1224_CR14","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/art.27186","volume":"62","author":"H Kokkonen","year":"2010","unstructured":"Kokkonen H, Soderstrom I, Rocklov J, Hallmans G, Lejon K, Rantapaa Dahlqvist S. Up-regulation of cytokines and chemokines predates the onset of rheumatoid arthritis. Arthritis Rheum. 2010;62(2):383\u201391.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"1224_CR15","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s00296-009-1356-y","volume":"30","author":"T Ichikawa","year":"2010","unstructured":"Ichikawa T, Kageyama Y, Kobayashi H, Kato N, Tsujimura K, Koide Y. Etanercept treatment reduces the serum levels of interleukin-15 and interferon-gamma inducible protein-10 in patients with rheumatoid arthritis. Rheumatol Int. 2010;30(6):725\u201330.","journal-title":"Rheumatol Int"},{"issue":"4","key":"1224_CR16","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3109\/03009742.2012.754937","volume":"42","author":"C Eriksson","year":"2013","unstructured":"Eriksson C, Rantapaa-Dahlqvist S, Sundqvist KG. Changes in chemokines and their receptors in blood during treatment with the TNF inhibitor infliximab in patients with rheumatoid arthritis. Scand J Rheumatol. 2013;42(4):260\u20135.","journal-title":"Scand J Rheumatol"},{"key":"1224_CR17","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13075-016-0995-0","volume":"18","author":"BK Han","year":"2015","unstructured":"Han BK, Kuzin I, Gaughan JP, Olsen NJ, Bottaro A. Baseline CXCL10 and CXCL13 levels are predictive biomarkers for tumor necrosis factor inhibitor therapy in patients with moderate to severe rheumatoid arthritis: a pilot, prospective study. Arthritis Res Ther. 2015;18:93.","journal-title":"Arthritis Res Ther."},{"issue":"2","key":"1224_CR18","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3899\/jrheum.090769","volume":"37","author":"WP Kuan","year":"2010","unstructured":"Kuan WP, Tam LS, Wong CK, Ko FW, Li T, Zhu T, Li EK. CXCL 9 and CXCL 10 as sensitive markers of disease activity in patients with rheumatoid arthritis. J Rheumatol. 2010;37(2):257\u201364.","journal-title":"J Rheumatol"},{"issue":"1","key":"1224_CR19","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780380107","volume":"38","author":"ML Prevoo","year":"1995","unstructured":"Prevoo ML, van \u2019t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995;38(1):44\u20138.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"1224_CR20","doi-asserted-by":"crossref","first-page":"R796","DOI":"10.1186\/ar1740","volume":"7","author":"D Aletaha","year":"2005","unstructured":"Aletaha D, Nell VP, Stamm T, Uffmann M, Pflugbeil S, Machold K, Smolen JS. Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score. Arthritis Res Ther. 2005;7(4):R796\u2013806.","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"1224_CR21","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/acr.21649","volume":"64","author":"J Anderson","year":"2012","unstructured":"Anderson J, Caplan L, Yazdany J, Robbins ML, Neogi T, Michaud K, Saag KG, O\u2019Dell JR, Kazi S. Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice. Arthritis Care Res. 2012;64(5):640\u20137.","journal-title":"Arthritis Care Res"},{"issue":"1","key":"1224_CR22","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cyto.2009.10.005","volume":"49","author":"HA Flytlie","year":"2010","unstructured":"Flytlie HA, Hvid M, Lindgreen E, Kofod-Olsen E, Petersen EL, Jorgensen A, Deleuran M, Vestergaard C, Deleuran B. Expression of MDC\/CCL22 and its receptor CCR4 in rheumatoid arthritis, psoriatic arthritis and osteoarthritis. Cytokine. 2010;49(1):24\u20139.","journal-title":"Cytokine"},{"issue":"3","key":"1224_CR23","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.autrev.2013.10.010","volume":"13","author":"A Antonelli","year":"2014","unstructured":"Antonelli A, Ferrari SM, Giuggioli D, Ferrannini E, Ferri C, Fallahi P. Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases. Autoimmun Rev. 2014;13(3):272\u201380.","journal-title":"Autoimmun Rev"},{"issue":"4","key":"1224_CR24","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1084\/jem.166.4.1084","volume":"166","author":"AD Luster","year":"1987","unstructured":"Luster AD, Ravetch JV. Biochemical characterization of a gamma interferon-inducible cytokine (IP-10). J Exp Med. 1987;166(4):1084\u201397.","journal-title":"J Exp Med"},{"issue":"5","key":"1224_CR25","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.autrev.2012.10.001","volume":"12","author":"EY Lee","year":"2013","unstructured":"Lee EY, Lee ZH, Song YW. The interaction between CXCL10 and cytokines in chronic inflammatory arthritis. Autoimmun Rev. 2013;12(5):554\u20137.","journal-title":"Autoimmun Rev"},{"issue":"2","key":"1224_CR26","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/icb.2010.158","volume":"89","author":"JR Groom","year":"2011","unstructured":"Groom JR, Luster AD. CXCR3 ligands: redundant, collaborative and antagonistic functions. Immunol Cell Biol. 2011;89(2):207\u201315.","journal-title":"Immunol Cell Biol"},{"issue":"5","key":"1224_CR27","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00296-004-0449-x","volume":"25","author":"A Ueno","year":"2005","unstructured":"Ueno A, Yamamura M, Iwahashi M, Okamoto A, Aita T, Ogawa N, Makino H. The production of CXCR3-agonistic chemokines by synovial fibroblasts from patients with rheumatoid arthritis. Rheumatol Int. 2005;25(5):361\u20137.","journal-title":"Rheumatol Int"},{"issue":"5","key":"1224_CR28","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1136\/annrheumdis-2012-202753","volume":"72","author":"J Lubbers","year":"2013","unstructured":"Lubbers J, Brink M, van de Stadt LA, Vosslamber S, Wesseling JG, van Schaardenburg D, Rantapaa-Dahlqvist S, Verweij CL. The type I IFN signature as a biomarker of preclinical rheumatoid arthritis. Ann Rheum Dis. 2013;72(5):776\u201380.","journal-title":"Ann Rheum Dis"},{"key":"1224_CR29","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s13075-016-1065-3","volume":"18","author":"TD Jong de","year":"2016","unstructured":"de Jong TD, Lubbers J, Turk S, Vosslamber S, Mantel E, Bontkes HJ, van der Laken CJ, Bijlsma JW, van Schaardenburg D, Verweij CL. The type I interferon signature in leukocyte subsets from peripheral blood of patients with early arthritis: a major contribution by granulocytes. Arthritis Res Ther. 2016;18:165.","journal-title":"Arthritis Res Ther."},{"key":"1224_CR30","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.coi.2015.03.001","volume":"34","author":"JE Allen","year":"2015","unstructured":"Allen JE, Sutherland TE, Ruckerl D. IL-17 and neutrophils: unexpected players in the type 2 immune response. Curr Opin Immunol. 2015;34:99\u2013106.","journal-title":"Curr Opin Immunol."},{"issue":"5","key":"1224_CR31","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.autrev.2008.12.002","volume":"8","author":"EY Lee","year":"2009","unstructured":"Lee EY, Lee ZH, Song YW. CXCL10 and autoimmune diseases. Autoimmun Rev. 2009;8(5):379\u201383.","journal-title":"Autoimmun Rev"},{"issue":"6","key":"1224_CR32","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1084\/jem.177.6.1809","volume":"177","author":"DD Taub","year":"1993","unstructured":"Taub DD, Lloyd AR, Conlon K, Wang JM, Ortaldo JR, Harada A, Matsushima K, Kelvin DJ, Oppenheim JJ. Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J Exp Med. 1993;177(6):1809\u201314.","journal-title":"J Exp Med"},{"issue":"3","key":"1224_CR33","doi-asserted-by":"crossref","first-page":"R104","DOI":"10.1186\/ar3385","volume":"13","author":"EY Lee","year":"2011","unstructured":"Lee EY, Seo M, Juhnn YS, Kim JY, Hong YJ, Lee YJ, Lee EB, Song YW. Potential role and mechanism of IFN-gamma inducible protein-10 on receptor activator of nuclear factor kappa-B ligand (RANKL) expression in rheumatoid arthritis. Arthritis Res Ther. 2011;13(3):R104.","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"1224_CR34","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.1002\/art.20615","volume":"50","author":"R Garcia-Vicuna","year":"2004","unstructured":"Garcia-Vicuna R, Gomez-Gaviro MV, Dominguez-Luis MJ, Pec MK, Gonzalez-Alvaro I, Alvaro-Gracia JM, Diaz-Gonzalez F. CC and CXC chemokine receptors mediate migration, proliferation, and matrix metalloproteinase production by fibroblast-like synoviocytes from rheumatoid arthritis patients. Arthritis Rheum. 2004;50(12):3866\u201377.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"1224_CR35","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.4049\/jimmunol.167.9.5381","volume":"167","author":"T Nanki","year":"2001","unstructured":"Nanki T, Nagasaka K, Hayashida K, Saita Y, Miyasaka N. Chemokines regulate IL-6 and IL-8 production by fibroblast-like synoviocytes from patients with rheumatoid arthritis. J Immunol. 2001;167(9):5381\u20135.","journal-title":"J Immunol"},{"issue":"8","key":"1224_CR36","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1002\/1529-0131(200008)43:8<1734::AID-ANR9>3.0.CO;2-B","volume":"43","author":"RM Borzi","year":"2000","unstructured":"Borzi RM, Mazzetti I, Cattini L, Uguccioni M, Baggiolini M, Facchini A. Human chondrocytes express functional chemokine receptors and release matrix-degrading enzymes in response to C-X-C and C-C chemokines. Arthritis Rheum. 2000;43(8):1734\u201341.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"1224_CR37","doi-asserted-by":"crossref","first-page":"R74","DOI":"10.1186\/ar616","volume":"5","author":"R Hanaoka","year":"2003","unstructured":"Hanaoka R, Kasama T, Muramatsu M, Yajima N, Shiozawa F, Miwa Y, Negishi M, Ide H, Miyaoka H, Uchida H, et al. A novel mechanism for the regulation of IFN-gamma inducible protein-10 expression in rheumatoid arthritis. Arthritis Res Ther. 2003;5(2):R74\u201381.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"1224_CR38","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1006\/clim.2000.4957","volume":"98","author":"DD Patel","year":"2001","unstructured":"Patel DD, Zachariah JP, Whichard LP. CXCR3 and CCR5 ligands in rheumatoid arthritis synovium. Clin Immunol. 2001;98(1):39\u201345.","journal-title":"Clin Immunol"},{"issue":"8","key":"1224_CR39","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00296-015-3234-0","volume":"35","author":"D Kotrych","year":"2015","unstructured":"Kotrych D, Dziedziejko V, Safranow K, Drozdzik M, Pawlik A. CXCL9 and CXCL10 gene polymorphisms in patients with rheumatoid arthritis. Rheumatol Int. 2015;35(8):1319\u201323.","journal-title":"Rheumatol Int"},{"issue":"5","key":"1224_CR40","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1186\/s13075-014-0434-z","volume":"16","author":"SR Greisen","year":"2014","unstructured":"Greisen SR, Schelde KK, Rasmussen TK, Kragstrup TW, Stengaard-Pedersen K, Hetland ML, Horslev-Petersen K, Junker P, Ostergaard M, Deleuran B, et al. CXCL13 predicts disease activity in early rheumatoid arthritis and could be an indicator of the therapeutic \u2018window of opportunity\u2019. Arthritis Res Ther. 2014;16(5):434.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"1224_CR41","doi-asserted-by":"crossref","first-page":"R34","DOI":"10.1186\/ar3742","volume":"14","author":"S Bugatti","year":"2012","unstructured":"Bugatti S, Manzo A, Benaglio F, Klersy C, Vitolo B, Todoerti M, Sakellariou G, Montecucco C, Caporali R. Serum levels of CXCL13 are associated with ultrasonographic synovitis and predict power Doppler persistence in early rheumatoid arthritis treated with non-biological disease-modifying anti-rheumatic drugs. Arthritis Res Ther. 2012;14(1):R34.","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"1224_CR42","doi-asserted-by":"crossref","first-page":"R28","DOI":"10.1186\/ar2381","volume":"10","author":"SW Syversen","year":"2008","unstructured":"Syversen SW, Goll GL, Haavardsholm EA, Boyesen P, Lea T, Kvien TK. A high serum level of eotaxin (CCL 11) is associated with less radiographic progression in early rheumatoid arthritis patients. Arthritis Res Ther. 2008;10(2):R28.","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"1224_CR43","doi-asserted-by":"crossref","first-page":"5546","DOI":"10.4049\/jimmunol.169.10.5546","volume":"169","author":"SR Vlahakis","year":"2002","unstructured":"Vlahakis SR, Villasis-Keever A, Gomez T, Vanegas M, Vlahakis N, Paya CV. G protein-coupled chemokine receptors induce both survival and apoptotic signaling pathways. J Immunol. 2002;169(10):5546\u201354.","journal-title":"J Immunol"},{"issue":"2","key":"1224_CR44","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cyto.2012.05.002","volume":"59","author":"AM Sidahmed","year":"2012","unstructured":"Sidahmed AM, Leon AJ, Bosinger SE, Banner D, Danesh A, Cameron MJ, Kelvin DJ. CXCL10 contributes to p38-mediated apoptosis in primary T lymphocytes in vitro. Cytokine. 2012;59(2):433\u201341.","journal-title":"Cytokine"},{"issue":"6","key":"1224_CR45","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1002\/art.34330","volume":"64","author":"M Yellin","year":"2012","unstructured":"Yellin M, Paliienko I, Balanescu A, Ter-Vartanian S, Tseluyko V, Xu LA, Tao X, Cardarelli PM, Leblanc H, Nichol G, et al. A phase II, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of MDX-1100, a fully human anti-CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis. Arthritis Rheum. 2012;64(6):1730\u20139.","journal-title":"Arthritis Rheum"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-017-1224-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T02:13:11Z","timestamp":1719022391000},"score":1,"resource":{"primary":{"URL":"http:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-017-1224-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,2]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1224"],"URL":"https:\/\/doi.org\/10.1186\/s13075-017-1224-1","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,2]]},"article-number":"20"}}